Michael Chambers - 10 Mar 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Michael Chambers
Issuer symbol
SRPT
Transactions as of
10 Mar 2025
Transactions value $
$0
Form type
4
Filing time
11 Mar 2025, 20:00:17 UTC
Previous filing
20 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award +2.38K +28.79% 10.7K 10 Mar 2025 Direct F1
holding SRPT Common Stock 284K 10 Mar 2025 By Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Options (right to buy) Award $0 +4.79K $0.00 4.79K 10 Mar 2025 Common Stock 4.79K $99.69 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.